Know Labs, Inc.

Transforming Non-Invasive Medical Diagnostics

Add To Watchlist
General Information
Company Name
Know Labs, Inc.
Founded Year
2003
Location (Offices)
Seattle, United States +1
Founders / Decision Makers
Ronald Erickson - Founder, Chief Executive Officer and Chairman Phil Bosua - CEO & Inventor James H Anderson - Chief Medical Officer Leonardo Trautwein - Chief Marketing Officer Masanori King Takee - VP, Software Engineering Christopher Somogyi - President International
Number of Employees
18
Industries
Hardware, Health Care, Medical Devices
Funding Stage
Post Ipo Debt
Social Media

Know Labs, Inc. - Company Profile

Know Labs, Inc. is a health care startup that aims to revolutionize non-invasive medical diagnostics. The company's proprietary technology platform utilizes radiofrequency (RF) dielectric spectroscopy and can be integrated into various wearable, mobile, or bench-top devices. Its inaugural application focuses on a non-invasive continuous blood glucose monitoring device designed to offer real-time data on blood glucose levels. This innovation is set to aid the management of diabetes and prediabetes for millions of individuals. Notably, Know Labs is a public company with shares trading under the stock symbol KNW on the NYSE American.

Founded in 2003 and headquartered in the United States, Know Labs recently secured a $4.00M post-IPO debt investment on 29 February 2024. This investment came from The Lind Partners, LLC, marking a significant milestone for the company's growth and development in the field of non-invasive medical diagnostics.

Taxonomy: Non-invasive diagnostics, Medical technology, Radiofrequency (RF) dielectric spectroscopy, Wearable technology, Mobile technology, Bench-top technology, Blood glucose monitoring, Real-time information, Diabetes management, Public company, Stock symbol KNW, NYSE American

Funding Rounds & Investors of Know Labs, Inc. (15)

View All
Funding Stage Amount No. Investors Investors Date
Post-IPO Debt $4.00M 1
The Lind Partners, LLC, investor in Know Labs, Inc.'s Post-IPO Debt round
29 Feb 2024
Post-IPO Equity $7.00M - 27 Sep 2023
Post-IPO Equity $14.20M - 15 Mar 2021
Post-IPO Equity $5.70M - 02 Jun 2020
Post-IPO Equity $300.00K - 29 Jan 2019

View All 15 Funding Rounds

Latest News of Know Labs, Inc.

View All

No recent news or press coverage available for Know Labs, Inc..

Similar Companies to Know Labs, Inc.

View All
GWave - Similar company to Know Labs, Inc.
GWave Developing a non-invasive technology that continuously measures blood glucose levels using RF waves.
Nemaura Medical - Similar company to Know Labs, Inc.
Nemaura Medical Innovative wearable diagnostic devices empowering individuals to manage and prevent diabetes through real-time glucose monitoring and actionable insights.
GlucoActive Sp. z o.o. - Similar company to Know Labs, Inc.
GlucoActive Sp. z o.o. A wearable device for non-invasive measurement of blood glucose concentration using spectrophotometric methods.
DiaMonTech AG - Similar company to Know Labs, Inc.
DiaMonTech AG Say goodbye to finger pricking!
GlucoSentient, Inc. - Similar company to Know Labs, Inc.
GlucoSentient, Inc.
Circle Decoration Circle Decoration

Want to dive deeper into Know Labs, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now